Tokai Pharmaceuticals Inc (TKAI)

5.02
0.12 2.33
NASDAQ : Health Care
Prev Close 5.14
Open 5.43
Day Low/High 4.98 / 5.43
52 Wk Low/High 3.42 / 18.83
Volume 7.56K
Avg Volume 15.20K
Exchange NASDAQ
Shares Outstanding 2.52M
Market Cap 13.81M
EPS -1.70
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

5 Stocks Under $10 Poised for Big Breakouts

5 Stocks Under $10 Poised for Big Breakouts

These under-$10 stocks are within range of triggering breakout trades. Here's how to play them.

INVESTOR ALERT: Investigation Into Tokai Pharmaceuticals IPO Announced By Holzer & Holzer LLC

INVESTOR ALERT: Investigation Into Tokai Pharmaceuticals IPO Announced By Holzer & Holzer LLC

Holzer & Holzer is investigating whether Tokai Pharmaceuticals, Inc.

These 5 Stocks Under $10 Could Make You a Lot of Money

These 5 Stocks Under $10 Could Make You a Lot of Money

Here's a technical look at how to trade several under-$10 triggering breakout trades.

First Week of May 2017 Options Trading For Tokai Pharmaceuticals (TKAI)

First Week of May 2017 Options Trading For Tokai Pharmaceuticals (TKAI)

Investors in Tokai Pharmaceuticals Inc saw new options become available this week, for the May 2017 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Tokai Pharmaceuticals, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of September 30, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Tokai Pharmaceuticals, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of September 30, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Tokai Pharmaceuticals, Inc.

TKAI INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Tokai Pharmaceuticals, Inc. And A Lead Plaintiff Deadline Of September 30, 2016

TKAI INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Tokai Pharmaceuticals, Inc. And A Lead Plaintiff Deadline Of September 30, 2016

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Tokai Pharmaceuticals, Inc.

Tokai Pharmaceuticals Announces Review Of Strategic Alternatives

Tokai Pharmaceuticals Announces Review Of Strategic Alternatives

Tokai Pharmaceuticals Inc. (NASDAQ: TKAI), a biopharmaceutical company focused on developing and commercializing innovative therapies for prostate cancer and other hormonally driven diseases, today announced that its...

Brower Piven Alerts Shareholders Of Upcoming Deadline In Class Action Lawsuit And Encourages Those With Losses From Investment In Tokai Pharmaceuticals, Inc. To Contact The Firm

Brower Piven Alerts Shareholders Of Upcoming Deadline In Class Action Lawsuit And Encourages Those With Losses From Investment In Tokai Pharmaceuticals, Inc. To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of...

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Tokai Pharmaceuticals, Inc. Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of September 30, 2016

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Tokai Pharmaceuticals, Inc. Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of September 30, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Tokai Pharmaceuticals, Inc.

TKAI INVESTOR ALERT: The Law Offices Of Vincent Wong Notifies Investors Of A Class Action Involving Tokai Pharmaceuticals, Inc. And A Lead Plaintiff Deadline Of September 30, 2016

TKAI INVESTOR ALERT: The Law Offices Of Vincent Wong Notifies Investors Of A Class Action Involving Tokai Pharmaceuticals, Inc. And A Lead Plaintiff Deadline Of September 30, 2016

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Tokai Pharmaceuticals, Inc.

SHAREHOLDER ALERT: Rosen Law Firm Reminds Tokai Pharmaceuticals, Inc. Investors Of Important Deadline In Class Action - TKAI

SHAREHOLDER ALERT: Rosen Law Firm Reminds Tokai Pharmaceuticals, Inc. Investors Of Important Deadline In Class Action - TKAI

Rosen Law Firm, a global investor rights law firm, reminds purchasers of Tokai Pharmaceuticals, Inc.

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Tokai Pharmaceuticals, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Tokai Pharmaceuticals, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of...

Tokai Pharmaceuticals, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors

Tokai Pharmaceuticals, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, and the securities litigation firm of Powers Taylor LLP announce that a federal class action lawsuit...

IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Tokai Pharmaceuticals, Inc. And Encourages Investors With Losses To Contact The Firm

IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Tokai Pharmaceuticals, Inc. And Encourages Investors With Losses To Contact The Firm

Lundin Law PC (the "Firm") announces that a class action lawsuit has been filed against Tokai Pharmaceuticals, Inc.

These 5 Stocks Under $10 Are Set to Soar Higher

These 5 Stocks Under $10 Are Set to Soar Higher

Here's a technical look at how to trade five stocks trading for less than $10 a share.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Tokai Pharmaceuticals, Inc. - TKAI

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Tokai Pharmaceuticals, Inc. - TKAI

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Tokai Pharmaceuticals, Inc.

INVESTOR NOTICE: Goldberg Law PC Announces Securities Class Action Lawsuit Against Tokai Pharmaceuticals, Inc. And Encourages Investors With Losses To Contact The Firm

INVESTOR NOTICE: Goldberg Law PC Announces Securities Class Action Lawsuit Against Tokai Pharmaceuticals, Inc. And Encourages Investors With Losses To Contact The Firm

Goldberg Law PC announces that a class action lawsuit has been filed against Tokai Pharmaceuticals, Inc.

Tokai Pharmaceuticals Announces Reduction In Force

Tokai Pharmaceuticals Announces Reduction In Force

Tokai Pharmaceuticals Inc. (NASDAQ: TKAI), a biopharmaceutical company focused on developing and commercializing innovative therapies for prostate cancer and other hormonally driven diseases, today announced that it is...

8 Stocks Under $10 to Trade for Huge Profits

8 Stocks Under $10 to Trade for Huge Profits

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces An Investigation Of Tokai Pharmaceuticals, Inc. And Advises Investors With Losses To Contact The Firm

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces An Investigation Of Tokai Pharmaceuticals, Inc. And Advises Investors With Losses To Contact The Firm

Lundin Law PC ( http://lundinlawpc.com/) announces that it is investigating claims against Tokai Pharmaceuticals, Inc.

INVESTOR ALERT: Investigation Of Tokai Pharmaceuticals Announced By Holzer & Holzer LLC

INVESTOR ALERT: Investigation Of Tokai Pharmaceuticals Announced By Holzer & Holzer LLC

Holzer & Holzer, LLC is investigating whether statements made by Tokai Pharmaceuticals, Inc.

Tokai Pharmaceuticals Announces Clinical Update

Tokai Pharmaceuticals Announces Clinical Update

Tokai Pharmaceuticals Inc. (NASDAQ:TKAI), a biopharmaceutical company focused on developing and commercializing innovative therapies for prostate cancer and other hormonally driven diseases, today announced that it...

These 5 Stocks Under $10 Are Set to Soar Higher

These 5 Stocks Under $10 Are Set to Soar Higher

Here's a technical look at how to trade five stocks trading for less than $10 a share that are headed for breakouts.

Tokai Pharmaceuticals To Participate In Upcoming Investor Conferences

Tokai Pharmaceuticals To Participate In Upcoming Investor Conferences

Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI), a biopharmaceutical company focused on developing and commercializing innovative therapies for prostate cancer and other hormonally driven diseases, today announced that...

Tokai Announces Publication of Three Abstracts on Galeterone at the 2016 ASCO Annual Meeting

Tokai Announces Publication of Three Abstracts on Galeterone at the 2016 ASCO Annual Meeting

Tokai Pharmaceuticals Inc. (NASDAQ: TKAI), a biopharmaceutical company focused on developing and commercializing innovative therapies for prostate cancer and other hormonally driven diseases, today announced that data...

Tokai Pharmaceuticals Reports First Quarter 2016 Financial Results

Tokai Pharmaceuticals Reports First Quarter 2016 Financial Results

Tokai Pharmaceuticals, Inc. (NASDAQ: TKAI), a biopharmaceutical company focused on developing and commercializing innovative therapies for prostate cancer and other hormonally driven diseases, today reported company...

Tokai Pharmaceuticals To Present At The Bank Of America Merrill Lynch 2016 Health Care Conference

Tokai Pharmaceuticals To Present At The Bank Of America Merrill Lynch 2016 Health Care Conference

Tokai Pharmaceuticals, Inc. (NASDAQ: TKAI), a biopharmaceutical company focused on developing and commercializing innovative therapies for prostate cancer and other hormonally driven diseases, today announced that...